Interestingly, both hBD-3 and LL-37 improve the human epidermal keratinocyte barrier function [26,27], and hBD-3 was recently demonstrated to alleviate AD symptoms in an AD-like murine model through autophagy activation [22]. This evidence concerns the gene CAMP and Alzheimer disease.